Sens. Rip FDA's 'Exaggerated' View Of Smoking Pleasure
The U.S. Food and Drug Administration is undercutting its own proposed rules to expand oversight on a variety of tobacco products including e-cigarettes by estimating an "exaggerated" 70 percent benefit reduction...To view the full article, register now.
Already a subscriber? Click here to view full article